[数字疗法在心血管疾病治疗中的应用]
Yuanshuai Chen1, Lina Zhao1,2,3,4
1The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310000.
概括
数字疗法,软件驱动干预,为心血管疾病管理提供了巨大的潜力. 它们增强了实时监控,个性化护理和遵守,优化了医疗保健的提供.
科学领域:
- 心脏病学 心脏病学
- 数字健康数字健康
- 医疗信息学 医疗信息学
背景情况:
- 数字疗法 (DTx) 是基于软件的干预措施,在医疗保健中越来越多的应用.
- 心血管疾病 (CVD) 构成了全球重大健康负担,需要创新的管理策略.
研究的目的:
- 概述DTx在心血管疾病管理中的优势.
- 分析DTx在常见心血管疾病中的临床价值和研究成果.
- 应对挑战,并提出基于证据的DTx在心脏病中的实施策略.
主要方法:
- 对心血管疾病的DTx研究结果的系统审查.
- 对临床应用价值和潜在益处的分析.
- 探索挑战,包括基于证据的实践,监管和数据安全.
主要成果:
- 对于心血管疾病,DTx提供实时监测,个性化管理,改善患者执法和医疗保健资源优化.
- 在各种常见的心血管疾病中显示出显著的临床潜力.
- 确定了基于证据的实践,监管框架和数据安全方面的挑战.
结论:
- DTx为改善心血管疾病治疗提供了一个有前途的途径.
- 解决实施挑战对于实现DTx.x的全部潜力至关重要.
- 开发高效,可访问和安全的数字诊断和治疗系统是关键.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Cardiomyopathy II: Dilated Cardiomyopathy
431
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
431
Coronary Artery Disease V: Interprofessional Care
203
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Cardiomyopathy V: Interprofessional Care
310
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
310
Heart Failure VI: Adjunct Therapies
233
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
233
Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291


